Difference between revisions of "Prostate cancer"

Jump to navigation Jump to search
1 byte added ,  00:18, 14 August 2014
Line 525: Line 525:
*Prostate carcinoma is typically CK7 -ve and CK20 -ve; however, high Gleason score cancers focal positivity of these markers can be seen.<ref name=pmid11888088>{{Cite journal  | last1 = Goldstein | first1 = NS. | title = Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. | journal = Am J Clin Pathol | volume = 117 | issue = 3 | pages = 471-7 | month = Mar | year = 2002 | doi = 10.1309/G6PR-Y774-X738-FG2K | PMID = 11888088 }}</ref>
*Prostate carcinoma is typically CK7 -ve and CK20 -ve; however, high Gleason score cancers focal positivity of these markers can be seen.<ref name=pmid11888088>{{Cite journal  | last1 = Goldstein | first1 = NS. | title = Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. | journal = Am J Clin Pathol | volume = 117 | issue = 3 | pages = 471-7 | month = Mar | year = 2002 | doi = 10.1309/G6PR-Y774-X738-FG2K | PMID = 11888088 }}</ref>
**CK7: >25-50% staining seen in ~5% of cases.
**CK7: >25-50% staining seen in ~5% of cases.
***>50% stained with CK7 is not report.
***>50% staining with CK7 is not report.
**CK20: >25-50% staining seen in ~10% of cases.
**CK20: >25-50% staining seen in ~10% of cases.
***>50% staining with CK20 is not reported.
***>50% staining with CK20 is not reported.
48,460

edits

Navigation menu